MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences

BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.
  • BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ:MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.
  • Piper Sandler raised the price target for Exact Sciences Corporation (NASDAQ:EXAS) from $40 to $50. Exact Sciences shares fell 2.6% to trade at $45.12 on Monday.
  • SVB Leerink cut the price target on AirSculpt Technologies, Inc. (NASDAQ:AIRS) from $27 to $8. AirSculpt Technologies shares dipped 4.6% to trade at $3.13 on Monday.
  • HC Wainwright & Co. cut the price target on RAPT Therapeutics, Inc. (NASDAQ:RAPT) from $53 to $50. RAPT Therapeutics shares fell 6.4% to trade at $22.62 on Monday.
  • Keybanc raised the price target for PulteGroup, Inc. (NYSE:PHM) from $47 to $51. PulteGroup shares fell 1.9% to trade at $43.51 on Monday.

Check out this: Unity Software, Amazon, Doximity And Other Big Gainers From Friday

Total
0
Shares
Related Posts
Read More

Maris-Tech Receives New Order From Returning Customer, A Leading Company In The Israeli Defense Company For The Co’s Advanced ‎Jupiter-Nano Platform, Which Provides Video Streaming Solutions On Advanced Drone ‎Applications, Total Amount Of $120,000

The Company's product will enable enhanced deep-learning AI applications on armored vehicles Rehovot, Israel, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (NASDAQ:MTEK) ("Maris-Tech" or the

MTEK